glp-1 inhibitor for weight loss The Agonists and Obesity: How Diabetes Drugs are Changing Non-Diabetic Lives — tl;dr pharmacy TrimRX | GLP-1 vs GIP:

The possible protective role of glucagon-like peptide 1 on endothelium during the meal and evidence for an endothelial resistance to glucagon-like peptide 1 in diabetes

Pregnant people who are taking these medications for weight loss can safely discontinue the medication under their healthcare providers supervision

Leiter LA, Bain SC, Hramiak I, Jdar E, Madsbad S, Gondolf T, et al

If headaches significantly impair quality of life or prevent continuation of treatment, the prescriber may consider dose adjustment, switching to an alternative medication, or discontinuation if necessary

No changes were made to other antidiabetic medications or lifestyle interventions during the observation period

Liraglutide treatment ameliorates IL-1-induced ROS production in cardiomyocytes, protects against IL-1-induced loss of mitochondrial membrane potential and decreased ATP generation, and counteracts IL-1-induced alterations in AMPK and acetyl-CoA carboxylase phosphorylation as well as the reduction of peroxisome proliferator-activated receptor coactivator-1 (PGC-1), which is a key regulator whose downregulation leads to cardiac mitochondrial dysfunction (168)